EMCDDA Home
  • EN
Search

Table TDI-111. Frequency of use of primary drug of clients entering outpatient treatment, 2011 or most recent year available

Part (vii) New cannabis outpatient clients by country and frequency of use (%)

CountryNot used in the past month/ OccasionalOnce a week or less2 - 6 times per weekDailyFrequency known (n)Frequency unknown
Belgium34.98.420.336.589842
Bulgaria42.928.628.670
Czech Republic16.833.331.318.529727
Denmark8.023.568.593299
Germany5.517.431.745.47994.0
Estonia47.410.531.610.519.0
Ireland115.37.922.054.883215
Greece17.624.025.133.345011
Spain112.37.317.762.772001453
France17.512.918.151.66038801
Italy226.030.018.625.443691412
Cyprus24.919.717.837.53092
Latvia311.362.317.09.45320
Lithuania
Luxembourg
Hungary62.919.49.78.0205137
Malta10.513.218.457.938
Netherlands10.92.411.775.025431491
Austria29.915.330.923.951136
Poland413.930.431.624.179.02.0
Portugal530.812.312.944.04489
Romania9.143.222.725.04416
Slovenia18.428.928.923.7381
Slovakia6.724.046.223.11042
Finland35.527.429.08.1627
Sweden140.017.526.815.755530
United Kingdom6
Croatia56.124.214.55.255818
Turkey
Norway
Total18.215.021.045.9364295531
 

Notes:

: Indicates no data are available.

Percentages are of clients whose frequency of use is known (n)

(1) Data are from 2010.

(2) In 2011 around 27% of all clients and 32% of new clients were registered as not known / missing for the primary drug category. Caution should be made when comparing data over time.

(3) In 2010 Latvia submitted a new dataset with a more precise TDI EMCDDA definition. Caution should be made when comparing data with previous years.

(4) Data are from 2010. Data presented in the table come from TDI pilot project. Caution should be made when interpreting the data.

(5) In 2010 came into implementation a new national information system implying methodological changes particularly in the registration criteria. Caution should be made when comparing 2010 data with previous years.

(6) Data are from 1st of April 2010 to 31st March 2011.

See also Table TDI-18 part(i), part(ii)

‘General notes for interpreting data'’ on the Explanatory notes and help page.

Source:

Reitox national reports 2012- Table TDI Outpatient Treatment Centres

About the EMCDDA

The European Monitoring Centre for Drugs and Drug Addiction (EMCDDA) is the reference point on drugs and drug addiction information in Europe. Inaugurated in Lisbon in 1995, it is one of the EU's decentralised agencies. Read more >>

Contact us

EMCDDA
Praça Europa 1, Cais do Sodré
1249-289 Lisbon
Portugal
Tel. (351) 211 21 02 00
Fax (351) 218 13 17 11

More contact options >>

Page last updated: Friday, 26 April 2013